Oxford Nanopore Technologies PLC develops technologies for molecular detection and analysis. The Company offers technologies that are used in deoxyribonucleic acid (DNA) sequencing, diagnostics, drug development, biomolecular interaction, ion channel screening, and defense applications. Oxford Nanopore Technologies serves customers worldwide.

H2 2025

Piper Sandler 37th Annual Healthcare Conference

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Oxford Nanopore Technologies (ONT LN)

H2 2025

Piper Sandler 37th Annual Healthcare Conference

Citi Annual Global Healthcare Conference 2025

Jefferies London Healthcare Conference 2025

Investor Update

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)